John Paul Johnson - 01 Mar 2023 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Financial Officer
Signature
Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
01 Mar 2023
Net transactions value
-$446,845
Form type
4
Filing time
03 Mar 2023, 16:37:47 UTC
Previous filing
23 Feb 2023
Next filing
26 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +20,413 +11% $0.000000 212,717 01 Mar 2023 Direct F1, F2, F3
transaction EVH Class A Common Stock Tax liability $129,792 -3,681 -1.7% $35.26 209,036 01 Mar 2023 Direct F3, F4
transaction EVH Class A Common Stock Tax liability $317,053 -9,020 -4.3% $35.15 200,016 02 Mar 2023 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. Omnibus Incentive Compensation Plan.
F2 Securities vest at a rate of 34% on March 1, 2024, and 33% on March 1, 2025, and March 1, 2026.
F3 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F4 This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.